Envision Report

Published January 10, 2018

Asia Pacific Regenerative Medicines Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Request Free Sample Report!

Regenerative medicine is a branch involved in the repair, replace and regenerate tissues and organs affected due to injury, disease or natural ageing process. These medicines can restore the functionality of cells and tissues and are used in various strategies like cell therapy, gene therapy, and tissue engineering.

Asia-Pacific Regenerative Medicines market share:

By application, the market is segmented into orthopaedic, oncology, diabetes, cardiology and central nervous system. Among this oncology is having the great share and fastest growth in the market.

Asia-Pacific Regenerative Medicines market size:

The market is valued at USD 17.625 Billion in 2017 and is expected to reach USD 51.453 Billion by 2024 at a CAGR of 23.8%.

The market is predominant in Asia-Pacific, and it continues during the forecast period. North America is in its growing phase and is holding the largest in regenerative medicines market as the therapies are in the 3rd phase of clinical trials.

Asia-Pacific Regenerative Medicines market growth:

The primary factors influencing the market growth are growing prevalence of chronic diseases such as bone and joint infections and trauma emergencies, increasing the need for orthopaedic surgeries, innovation in stem cell therapy, technological innovations and tissue engineering.

Asia-Pacific Regenerative Medicines industry analysis:

The market is majorly divided into products, application, therapy, material and agent type. By-products it is segmented into cell-based and acellular, and by therapy, the market is segmented into the cell, therapy, tissue and gene therapy. By application, the market is segmented into orthopaedic, dermatology, cardiology, oncology and central nervous system. By material, the market is categorised into algae-derived alginate, synthetic polymer, polylactide- coglycolide, polyethylene glycol and hydrogels. Final segmentation is based on agent type it is into biologics, cell-based medical devices, and biopharmaceuticals.

Asia-Pacific Regenerative Medicines Market Outlook:

Regenerative medicines are those have the ability to repair, replace and regenerate tissues and organs of affected due to disease, injury and natural ageing process. Many industries and firms are trying to develop new technologies and advancements to improve the market growth.

Asia-Pacific Regenerative Medicines Market Trends:

Recent acquisitions in biotechnology are leading the regenerative medical industry have favourable growth. Medtronic acquired heart wave international which is a provider of technologies for mechanical circulatory support for patient’s treatment. This acquisition further is projected to have the company by broadening its products portfolio.

Asia-Pacific Regenerative Medicines Market Research Report Includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis through industry value chain analysisPorter’s fivePESTLESWOT analysis, and Y-o-Y analysis.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on YearOnYear
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • Identify the latest developments, market shares and strategies that are employed by the major market players, such as
  • Mesoblast Ltd
  • Athersys
  • Neuralstem Inc.
  • Neo Stem Inc.

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 DROC

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

Chapter 5 Market Segmentation Analysis

Chapter 6 Market Segmentation by Product

6.1 Introduction

6.2 Cell-based products

6.2.1 Allogeneic products

6.2.2 Autologous products

6.3 Acellular products

Chapter 7 Market Segmentation by Application

7.1 Introduction

7.2 Orthopaedic and musculoskeletal disorders

7.3 Dermatology

7.4 Cardiology

7.5 Central nervous system diseases

7.6 Oncology

7.7 Diabetes

7.8 Bone graft substitutes

7.9 Others

Chapter 8 Market Segmentation by Therapy

8.1 Introduction

8.2 Cell therapy

8.3 Immunotherapy

8.4 Tissue therapy

8.5 Gene therapy

8.6 Others

Chapter 9 Market Segmentation by Material

9.1 Introduction

9.2 Algae-derived alginate

9.3 Synthetic polymer

9.4 Poly-lactide-coglycolide

9.5 Poly-ethylene glycol

9.6 Hydrogels

9.7 Others

Chapter 10 Market Segmentation by Agent type

10.1 Introduction

10.2 Biologics

10.2.1 Autologous fibroblasts

10.2.2 Hematopoietic stem and progenitor cells

10.3 Cell-based medical devices

10.3.1 Allogenic fibroblasts

10.3.2 Cell extraction

10.4 Biopharmaceuticals

10.4.1 Tricalcium phosphate

10.4.2 Osteogenic protein

Chapter 11 Market Segmentation by Geography

11.1 Asia-pacific

11.1.1 Introduction

11.1.2 China

11.1.3 Japan

11.1.4 India

11.1.5 Australia & New Zealand

11.1.6 Others

Chapter 12 Competitive Landscape

12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

12.2 Market Share Analysis

12.3 Strategies Adopted By Top Companies

Chapter 13 Company Profiles

13.1 StemCells Inc.

            13.1.1 Business Overview

13.1.2 Product portfolio

13.1.3 Key Strategy

13.1.4 Recent Developments

13.2 Mesoblast Ltd

13.3 Athersys Inc.

13.4 Neuralstem Inc.

13.5 Neo Stem Inc.

Chapter 14 Market Estimates and Forecast

14.1 Market Estimates and forecast 2018-2024(USD Billion)

14.1.1 Market Estimates and forecast by Product 2018-2024(USD Billion)

14.1.2 Market Estimates and forecast by Application 2018-2024(USD Billion)

14.1.3 Market Estimates and forecast by Therapy 2018-2024(USD Billion)

14.1.4 Market Estimates and forecast by Material 2018-2024(USD Billion)

14.1.5 Market Estimates and forecast by Agent type 2018-2024(USD Billion)

14.1.6 Market Estimates and forecast by geography 2018-2024(USD Billion)

Chapter 15 Market Insights

15.1 Insights of Industry Experts

15.2 Analyst Opinion (Market Understanding)

15.3 Investment Opportunities

Chapter 16 Appendix

16.1 List of Tables

16.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

 

©2018 - Envision Inteligence | All Rights Reserved.